Manganese-based MRI contrast agents: past, present, and future
Top Cited Papers
- 30 July 2011
- journal article
- review article
- Published by Elsevier in Tetrahedron
- Vol. 67 (44), 8431-8444
- https://doi.org/10.1016/j.tet.2011.07.076
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Magnetic resonance in the era of molecular imaging of cancerMagnetic Resonance Imaging, 2011
- Synthesis and Evaluation of Nanoglobular Macrocyclic Mn(II) Chelate Conjugates as Non-Gadolinium(III) MRI Contrast AgentsBioconjugate Chemistry, 2011
- Mesoporous Silica-Coated Hollow Manganese Oxide Nanoparticles as Positive T1 Contrast Agents for Labeling and MRI Tracking of Adipose-Derived Mesenchymal Stem CellsJournal of the American Chemical Society, 2011
- Manganese-Enhanced Magnetic Resonance Imaging (MEMRI)Published by Springer Nature ,2010
- HSA coated MnO nanoparticles with prominent MRI contrast for tumor imagingChemical Communications, 2010
- MRI Sensing Based on the Displacement of Paramagnetic Ions from Chelated ComplexesInorganic Chemistry, 2010
- Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloidsChemical Communications, 2009
- Convertible manganese contrast for molecular and cellular MRIMagnetic Resonance in Medicine, 2008
- MR tracking of transplanted cells with “positive contrast” using manganese oxide nanoparticlesMagnetic Resonance in Medicine, 2008
- Ligand-Directed Nanobialys as Theranostic Agent for Drug Delivery and Manganese-Based Magnetic Resonance Imaging of Vascular TargetsJournal of the American Chemical Society, 2008